After a private company gained exclusive rights of a progesterone drug used to prevent premature births in at-risk mothers, the price of the shot spiked from $30 to $1,500. Wyatt Andrews reports
Read More »After a private company gained exclusive rights of a progesterone drug used to prevent premature births in at-risk mothers, the price of the shot spiked from $30 to $1,500. Wyatt Andrews reports
Read More »